A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease.
about
Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's diseaseMRI and CSF studies in the early diagnosis of Alzheimer's disease.Cube drawing performances in normal ageing and Alzheimer's disease: data from the PAQUID elderly population-based cohort.Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.The prediction and prevention of Alzheimer's disease--towards a research agendaSubregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment.Is there a neuropathology difference between mild cognitive impairment and dementia?Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery.Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.Age-related changes in the attentional control of visual cortex: a selective problem in the left visual hemifield.Subjective memory in older African Americans.Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?Mild cognitive impairment: a review and nursing implications.Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.Mild cognitive impairment: believe it or not?Neuropsychological prediction of decline to dementia in nondemented elderly.Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly.Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels.The global deterioration scale: relationships to neuropsychological performance and activities of daily living in patients with vascular dementia.A longitudinal study of cognitive function in elderly persons with subjective memory complaints.Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.
P2860
Q22251334-B00ACF18-0523-4A5A-8016-F9E37D976D8FQ30953178-9E5D8F38-E40F-41B8-B5F4-063E9541BD06Q31013862-41D0434E-3A01-4112-B645-0766516AF61EQ31566966-FD0586D2-C6CF-4825-8637-6176B2C93AA6Q33454243-E6D422A6-B486-4930-B283-71F0F5DDC440Q33787542-6A39A5C7-1A51-41B5-864F-0F8572024A14Q33862533-3FC82BA4-72C3-499B-A549-8FBBBB5ED177Q33921966-B0795827-A32C-4F72-8CF9-7EED659F0136Q33944002-6CCBA8E5-B04A-4BB4-8541-6C847C74572AQ34752921-5CEACEAA-1EC4-4890-8DF8-0D40C03A690FQ34776816-060BDC8A-4AC5-4E6B-BBFD-C0F0469D9693Q35017028-D652BE45-EAF7-485D-99C8-1B226E0A5096Q35472824-F8E431E3-FF40-4BCD-81D4-1F94336A8F12Q36445755-FA24C99B-5F00-41DE-95B4-579040812056Q36817992-AC226F20-07FB-4BCC-AAE8-B8D9559548A5Q36939128-0A9156AA-F1D8-4276-94AB-B4AA34D9220BQ37139165-FB1A1D55-72B5-46BF-96BD-67F22640FED9Q37141212-0D3954AB-1315-4DE9-A50D-84CC83F8A156Q37299901-DD21FFC9-A9DE-4DDF-8F0B-E732615E2847Q40784342-1CACF749-6712-4233-92A1-FCDF8EF7F835Q44944057-98223F31-8339-4B1D-A163-9C606790AE99Q46823529-738C3C04-E6A6-448E-AC79-A716CE879BB4Q51567441-247AD49D-0178-44B1-BCA6-5206896CE21AQ51958180-9E4495DD-5066-4BCF-B67E-8DDDC0335049Q52060820-5BE97046-130B-4784-860D-BF27ABF127E6Q53325570-9E639655-7FCA-488D-BB17-186BF7073C7D
P2860
A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
A two-year longitudinal study ...... aging and Alzheimer's disease.
@en
A two-year longitudinal study ...... aging and Alzheimer's disease.
@nl
type
label
A two-year longitudinal study ...... aging and Alzheimer's disease.
@en
A two-year longitudinal study ...... aging and Alzheimer's disease.
@nl
prefLabel
A two-year longitudinal study ...... aging and Alzheimer's disease.
@en
A two-year longitudinal study ...... aging and Alzheimer's disease.
@nl
P2860
P1476
A two-year longitudinal study ...... aging and Alzheimer's disease.
@en
P2093
P2860
P356
10.1177/089198879300600205
P577
1993-04-01T00:00:00Z